| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/20/2009 | CA2165935C Calibrating and testing immunoassays to minimize interferences |
| 10/15/2009 | WO2009126970A1 Method of assessing sensitivity to brostallicin |
| 10/15/2009 | WO2009126966A2 Genetic markers indicating biological response to a plk1 kinase inhibitor |
| 10/15/2009 | WO2009126894A2 Methods and compositions for the diagnosis and treatment of angiogenic disorders |
| 10/15/2009 | WO2009126889A1 Assays for detecting pregnancy- associated glycoproteins |
| 10/15/2009 | WO2009126883A2 Nucleic acid binding substance containing catalytic nucleation nanoparticles |
| 10/15/2009 | WO2009126841A1 Enzymatic biosensors with enhanced activity retention for detection of organic compounds |
| 10/15/2009 | WO2009126828A2 Capture agents and related methods and systems for detecting and/or sorting targets |
| 10/15/2009 | WO2009126804A2 Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis |
| 10/15/2009 | WO2009126801A2 Synthetically functionalized living cells |
| 10/15/2009 | WO2009126733A1 Method of detecting canine exercise-induced collapse |
| 10/15/2009 | WO2009126730A2 Canine single chain fragment variable antibody libraries and uses thereof |
| 10/15/2009 | WO2009126727A1 Rna compositions for modulating immune response |
| 10/15/2009 | WO2009126726A1 Methods and compositions for diagnosing and modulating human papillomavirus (hpv) |
| 10/15/2009 | WO2009126718A2 Tumor-associated biomarkers from the dark proteom |
| 10/15/2009 | WO2009126717A2 A genetically encoded sensor for pkc-gamma activation and signaling |
| 10/15/2009 | WO2009126678A2 Detection of target nucleic acid sequences using fluorescence resonance energy transfer |
| 10/15/2009 | WO2009126632A1 Compositions and methods for the use of mutant t3 rna polymerases in the synthesis of modified nucleic acid transcripts |
| 10/15/2009 | WO2009126543A1 Biomarker panel for prediction of recurrent colorectal cancer |
| 10/15/2009 | WO2009126524A2 Three-dimensional microfluidic platforms and methods of use thereof |
| 10/15/2009 | WO2009126517A2 Optimized probes and primers and methods of using same for the detection, quantification and grouping of hiv-1 |
| 10/15/2009 | WO2009126498A2 Device for oral cavity examination |
| 10/15/2009 | WO2009126395A1 Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule |
| 10/15/2009 | WO2009126380A2 Methods and compositions for highly sensitive detection of molecules |
| 10/15/2009 | WO2009126343A2 Oil emulsions and methods for manufacture and use thereof |
| 10/15/2009 | WO2009126310A2 Methods for identification and use of agents targeting cancer stem cells |
| 10/15/2009 | WO2009126290A2 Coferons and methods of making and using them |
| 10/15/2009 | WO2009126271A1 Methods, agents and kits for the detection of cancer |
| 10/15/2009 | WO2009126122A1 Prostate cancer-specific alterations in erg gene expression and detection and treatment methods based on those alterations |
| 10/15/2009 | WO2009126110A1 Method of determining hypoxia |
| 10/15/2009 | WO2009125936A2 Analysis method and kit for diagnosis of polycystic ovary syndrome |
| 10/15/2009 | WO2009125930A1 Bio-sensor |
| 10/15/2009 | WO2009125851A1 Method for detection of effectiveness of phenylalanine derivative-type compound in diabetes patient |
| 10/15/2009 | WO2009125826A1 Gene capable of being expressed specifically in endosperm of plant, promoter for the gene, and use of the gene and the promoter |
| 10/15/2009 | WO2009125804A1 Screening method |
| 10/15/2009 | WO2009125798A1 Method for screening of pharmaceutical candidate substance for treatment of cancer in which hedgehog pathway is activated |
| 10/15/2009 | WO2009125646A1 Tdp-43-storing cell model |
| 10/15/2009 | WO2009125604A1 Method for screening olfactory sensibility inhibitor |
| 10/15/2009 | WO2009125296A2 Genetic markers of wound development |
| 10/15/2009 | WO2009125228A1 Rapid detection of mycobacteria |
| 10/15/2009 | WO2009125067A1 Microfluidic chip devices and their use |
| 10/15/2009 | WO2009125065A1 Correcting biological signal measurements from parallel measurement devices |
| 10/15/2009 | WO2009125043A1 Method and system for detecting and/or quantifying bacteriophages, use of a microelectronic sensor device for detecting said bacteriophages and microelectronic sensor device for implementing said method |
| 10/15/2009 | WO2009125020A1 Method for profiling drug compounds |
| 10/15/2009 | WO2009125019A1 Method for tumor classification |
| 10/15/2009 | WO2009125016A1 New method for selecting compounds useful for treating and/or preventing microbial shigella infection |
| 10/15/2009 | WO2009124749A1 Method for analysing the epigenetic status of the htra 1 gene in a biological sample |
| 10/15/2009 | WO2009124720A1 Androgenetic alopecia |
| 10/15/2009 | WO2009124665A1 Detection of pcr products in gel electrophoresis |
| 10/15/2009 | WO2009124404A1 Methods of diagnosing acute cardiac allograft rejection |
| 10/15/2009 | WO2009124403A1 Methods of diagnosing chronic cardiac allograft rejection |
| 10/15/2009 | WO2009124396A1 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity |
| 10/15/2009 | WO2009124391A1 Anti-angiogenesis, anticancer proliferation properties of lymphocytic-derived microparticles |
| 10/15/2009 | WO2009124341A1 Rna molecules and uses thereof |
| 10/15/2009 | WO2009100188A3 Methods for detection of corn event das-59132 |
| 10/15/2009 | WO2009100008A3 Genetic methods for speciating campylobacter |
| 10/15/2009 | WO2009098717A3 Method to characterize a protein as rna binding protein |
| 10/15/2009 | WO2009098045A8 Method and kit for detecting, diagnosing or controlling the treatment of ovarian cancer |
| 10/15/2009 | WO2009097368A3 Methods and compositions for efficient base calling in sequencing reactions |
| 10/15/2009 | WO2009097270A3 Method of determining breast cancer risk |
| 10/15/2009 | WO2009095641A3 Enhanced plant growth |
| 10/15/2009 | WO2009092087A3 Selective differentiation, identification, and modulation of human th17 cells |
| 10/15/2009 | WO2009092035A3 Methods and compositions for the analysis of biological molecules |
| 10/15/2009 | WO2009087688A3 Method for detection of nucleic acid of mycobacterium and uses thereof |
| 10/15/2009 | WO2009087685A3 Method for detection of hepatitis nucleic acid and uses thereof |
| 10/15/2009 | WO2009085355A3 Biological specimen collection and transport system and methods of use |
| 10/15/2009 | WO2009082488A3 Methods for creating and identifying functional rna interference elements |
| 10/15/2009 | WO2009080817A3 Mobile rapid test system for nucleic acid analysis |
| 10/15/2009 | WO2009076651A3 Methods for identifying compounds that modulate lisch-like protein or c1orf32 protein activity and methods of use |
| 10/15/2009 | WO2009076485A3 Sequencing of nucleic acids |
| 10/15/2009 | WO2009076057A3 Methods and compositions relating to multiplexed genomic gain and loss assays |
| 10/15/2009 | WO2009071841A3 Egr1 modulators used in the treatment of alopecia |
| 10/15/2009 | WO2009065511A3 Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders |
| 10/15/2009 | WO2009063249A3 Early detection of sepsis |
| 10/15/2009 | WO2009038840A3 Compositions for use in identification of adventitious contaminant viruses |
| 10/15/2009 | US20090260100 Pea line 08540794 |
| 10/15/2009 | US20090260099 Dry bean line 08550811 |
| 10/15/2009 | US20090260095 Gene Marker for Evaluating Genetic Ability for Carcass Weight in Bovine and Method for Evaluating Genetic Ability for Carcass Weight Using the Same |
| 10/15/2009 | US20090260094 Stearoyl-CoA Desaturase 4 Gene |
| 10/15/2009 | US20090260092 Methods of diagnosing alzheimer's disease and markers identified by set association |
| 10/15/2009 | US20090260091 Using mutation in gene associated with monocyte chemoattractant protein-1detect, diagnose, prevent and treat vision disorders; Ccr2-deficient mice; drug screening |
| 10/15/2009 | US20090260090 Apobec3 mediated dna editing |
| 10/15/2009 | US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 10/15/2009 | US20090258931 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry |
| 10/15/2009 | US20090258929 Compositions and Methods for Modulating mTOR Signaling |
| 10/15/2009 | US20090258928 Methods and compositions for diagnosing and modulating human papillomavirus (hpv) |
| 10/15/2009 | US20090258925 Natural antisense and non-coding rna transcripts as drug targets |
| 10/15/2009 | US20090258914 Inhibitor of Anti-Apoptotic Proteins |
| 10/15/2009 | US20090258848 Biomarkers for inflammatory bowel disease |
| 10/15/2009 | US20090258834 Plasma protein-binding ligands |
| 10/15/2009 | US20090258828 Investigation of mucosa dryness conditions |
| 10/15/2009 | US20090258825 HOPM1 Mediated disease resistance to Pseudomonas syringae in Arabidopsis |
| 10/15/2009 | US20090258822 Diagnosis and Treatment of Age-Related Macular Degeneration |
| 10/15/2009 | US20090258795 Gene expression markers for prediction of patient response to chemotherapy |
| 10/15/2009 | US20090258793 libraries of nucleic acid species each comprising a transcription unit having a promoter region operatively linked to a coding sequence; enable the indirect detection and analysis of particular biomolecules, for example, by mass spectrometry |
| 10/15/2009 | US20090258789 Methods of determining the prognosis of an adenocarcinoma |
| 10/15/2009 | US20090258440 Surface for label independent detection and method thereof |
| 10/15/2009 | US20090258425 Gene knock-down by intracellular expression of aptamers |
| 10/15/2009 | US20090258422 Optically detectable organophosphonates |
| 10/15/2009 | US20090258414 Devices for PCR and for observing nucleic acid hybridization with fluorescence dye during and/or immediately after PCR and using this information for product identification, sequence alteration detection, and quantification; fluorescence resonance energy transfer (fret) |